Detalles de la búsqueda
1.
A European, prospective, observational study of enzalutamide in patients with metastatic castration-resistant prostate cancer: PREMISE.
Int J Cancer
; 150(5): 837-846, 2022 03 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34648657
2.
Italian results of the PRECONNECT study: safety and efficacy of trifluridine/tipiracil in metastatic colorectal cancer.
Future Oncol
; 17(18): 2315-2324, 2021 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-33663264
3.
Upfront FOLFOXIRI plus bevacizumab and reintroduction after progression versus mFOLFOX6 plus bevacizumab followed by FOLFIRI plus bevacizumab in the treatment of patients with metastatic colorectal cancer (TRIBE2): a multicentre, open-label, phase 3, randomised, controlled trial.
Lancet Oncol
; 21(4): 497-507, 2020 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-32164906
4.
Phase II study on first-line treatment of NIVolumab in combination with folfoxiri/bevacizumab in patients with Advanced COloRectal cancer RAS or BRAF mutated - NIVACOR trial (GOIRC-03-2018).
BMC Cancer
; 20(1): 822, 2020 Aug 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-32867715
5.
Endocrine therapy for hormone receptor-positive, HER2-negative metastatic breast cancer: extending endocrine sensitivity.
Future Oncol
; 16(5): 129-145, 2020 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-31849236
6.
DPYD*6 plays an important role in fluoropyrimidine toxicity in addition to DPYD*2A and c.2846A>T: a comprehensive analysis in 1254 patients.
Pharmacogenomics J
; 19(6): 556-563, 2019 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-30723313
7.
Buparlisib plus fulvestrant in postmenopausal women with hormone-receptor-positive, HER2-negative, advanced breast cancer progressing on or after mTOR inhibition (BELLE-3): a randomised, double-blind, placebo-controlled, phase 3 trial.
Lancet Oncol
; 19(1): 87-100, 2018 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29223745
8.
Estimating Survival Probabilities of Advanced Gastric Cancer Patients in the Second-Line Setting: The Gastric Life Nomogram.
Oncology
; 95(6): 344-352, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-30130791
9.
Outcomes of Advanced Gastric Cancer Patients Treated with at Least Three Lines of Systemic Chemotherapy.
Oncologist
; 22(12): 1463-1469, 2017 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-28860412
10.
Everolimus Plus Exemestane in Advanced Breast Cancer: Safety Results of the BALLET Study on Patients Previously Treated Without and with Chemotherapy in the Metastatic Setting.
Oncologist
; 22(6): 648-654, 2017 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-28432226
11.
Evaluation of erlotinib treatment response in non-small cell lung cancer using metabolic and anatomic criteria.
Q J Nucl Med Mol Imaging
; 60(3): 264-73, 2016 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-27463889
12.
A multicenter phase II trial of nab-paclitaxel and capecitabine in HER-2 negative and triple- negative advanced breast cancer: Could be an old regimen a valid approach to a changing disease?
Breast J
; 26(9): 1857-1859, 2020 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32436244
13.
[Sequential inhibition of angiogenesis in metastatic colorectal cancer: activity and efficacy of aflibercept]. / Inibizione sequenziale dell'angiogenesi nel carcinoma del colon-retto metastatico: attività ed efficacia di aflibercept in un caso clinico.
Recenti Prog Med
; 106(5): 239e-43e, 2015 May.
Artículo
en Italiano
| MEDLINE | ID: mdl-25994542
14.
Translational challenges from the 2014 Gastrointestinal Cancers Symposium: toward a true tailored therapy through effective research.
Future Oncol
; 10(7): 1125-8, 2014 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-24947252
15.
Phase II randomized trial comparing metronomic anthracycline-containing chemotherapy versus standard schedule in untreated HER2 negative advanced breast cancer: activity and quality of life results of the GOIM 21003 trial.
Breast
; 75: 103725, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38615483
16.
Fluorouracil, Leucovorin, and Irinotecan Plus Cetuximab Versus Cetuximab as Maintenance Therapy in First-Line Therapy for RAS and BRAF Wild-Type Metastatic Colorectal Cancer: Phase III ERMES Study.
J Clin Oncol
; 42(11): 1278-1287, 2024 Apr 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-38181312
17.
The Italian Rare Biliary tract Cancer initiative (IRaBiCa): A multicentric observational study of Gruppo Oncologico dell'Italia Meridionale (GOIM) in collaboration with Gruppo Italiano Colangiocarcinoma (GICO).
Tumori
; : 3008916231222761, 2024 Feb 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-38326240
18.
Dose-dense FEC followed by dose-dense ixabepilone as neoadjuvant treatment for breast cancer patients: a feasibility study.
Oncologist
; 18(8): 924-5, 2013.
Artículo
en Inglés
| MEDLINE | ID: mdl-23939283
19.
Outcomes of Advanced Gastric Cancer Patients Treated with at Least Three Lines of Systemic Chemotherapy.
Oncologist
; 23(2): 272, 2018 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-29449512
20.
Panitumumab Plus Trifluridine-Tipiracil as Anti-Epidermal Growth Factor Receptor Rechallenge Therapy for Refractory RAS Wild-Type Metastatic Colorectal Cancer: A Phase 2 Randomized Clinical Trial.
JAMA Oncol
; 9(7): 966-970, 2023 07 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37200022